表皮生长因子受体基因在多种肿瘤中的突变情况及临床意义

被引：12

作者：

武晓楠

机构：

[1] 卫生部北京医院肿瘤内科

来源：

中国全科医学 | 2008年 / 13期

关键词：

表皮生长因子受体; 基因突变; 肿瘤;

D O I：

暂无

中图分类号：

R730.2 [肿瘤病理学、病因学]; R730.5 [肿瘤治疗学];

学科分类号：

100214 ;

摘要：

表皮生长因子受体基因在肿瘤细胞中通过点突变、扩增或缺失实现其蛋白功能的变化和调节其相关分子靶向药物的反应性。本文着重介绍了包括非小细胞肺癌、头颈部鳞癌、结直肠癌、胰腺癌、肝胆系统肿瘤、食管癌和胃癌、乳腺癌和卵巢癌、神经胶质瘤等多种肿瘤组织中表皮生长因子受体基因酪氨酸激酶区的突变状态及与分子靶向药物治疗相关的临床意义。

引用

页码：1197 / 1201

页数：5

共 14 条

[1] 相关基因的单核苷酸多态性与肿瘤的遗传易感 [J].

柯杨 .

中华肿瘤杂志, 2002, (02) :5-6

[2]

EGFR, ERBB2 , and KRAS mutations in Korean non-small cell lung cancer patients[J] . Nack Cheon Bae,Myung Hwa Chae,Myung Hoon Lee,Kyung Mee Kim,Eung Bae Lee,Chang Ho Kim,Tae-In Park,Sung Beom Han,Sanghoon Jheon,Tae Hoon Jung,Jae Yong Park.Cancer Genetics and Cytogenetics . 2007 (2)

[3]

Erlotinib: success of a molecularly targeted agent for the treatment of advanced pancreatic cancer[J] . Stephen A Welch,Malcolm J Moore.Future Oncol. . 2007 (3)

[4] EGFRvIII mutation in lung cancer correlates with increased EGFR copy number [J].

Sasaki, Hidefumi ;

Kawano, Osamu ;

Endo, Katsuhiko ;

Yukiue, Haruhiro ;

Yano, Motoki ;

Fujii, Yoshitaka .

ONCOLOGY REPORTS, 2007, 17 (02) :319-323

[5]

Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma:A comparative study using immunohistochemistry correlated with gene amplificationby fluorescencent in situ hybridization[J] . Jane Dancer,Hidehiro Takei,Jae Ro,Mary Lowery-Nordberg.Oncology Reports . 2007 (1)

[6]

Epidermal Growth Factor Receptor Mutations and Their Correlation with Gefitinib Therapy in Patients with Non-small Cell Lung Cancer: A Meta-Analysis Based on Updated Individual Patient Data from Six Medical Centers in Mainland China[J] . Yi-Long Wu,Wen-Zhao Zhong,Long-Yun Li,Xiao-Tong Zhang,Li Zhang,Cai-Cun Zhou,Wei Liu,Bin Jiang,Xin-Lin Mu,Jia-Ying Lin,Qing Zhou,Chong-Rui Xu,Zhen Wang,Guo-Chun Zhang,Tony Mok.Journal of Thoracic Oncology . 2007 (5)

[7] Lack of EGFR gene mutations in exons 19 and 21 in esophageal (Barrett's) adenocarcinomas [J].

Puehringer-Oppermann, F. A. ;

Stein, H. J. ;

Sarbia, M. .

DISEASES OF THE ESOPHAGUS, 2007, 20 (01) :9-11

[8]

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma[J] . Heini Lassus,Harri Sihto,Arto Leminen,Heikki Joensuu,Jorma Isola,Nina N. Nupponen,Ralf Butzow.Journal of Molecular Medicine . 2006 (8)

[9] Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas [J].